… association between ALOX5 promoter genotype and the response to anti-asthma treatment -
JM Drazen, CN Yandava, L Dub?, N Szczerback, R … - Nature Genetics, 1999 - nature.com
... Nature Genetics 22, 168 - 170 (1999) doi:10.1038/9680 Pharmacogenetic association
between ALOX5 promoter genotype and the response to anti-asthma treatment. ...
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway -
JM Drazen, E Israel, PM O'Byrne - New England Journal of Medicine, 1999 - content.nejm.org
... Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent
asthma treatment: systematic review of current evidence. ...
… , a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced … -
JA Leff, WW Busse, D Pearlman, EA Bronsky, J Kemp, … - New England Journal of Medicine, 1998 - content.nejm.org
... S. (2006). Improvements in Distal Lung Function Correlate With Asthma Symptoms
After Treatment With Oral Montelukast. Chest 130: 1726 ...
Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect … -
WT Watson, AB Becker, FE Simons - J Allergy Clin Immunol, 1993 - ncbi.nlm.nih.gov
... decreases bronchial hyperreactivity. Ignoring inflammation in the upper
airway may lead to suboptimal results in asthma treatment. ...
… of Asthma when Using Airway Hyperresponsiveness as an Additional Guide to Long-Term Treatment -
JK SONT, LNA WILLEMS, EH BEL, JHANJM van KRIEKEN, … - American Journal of Respiratory and Critical Care Medicine, 1999 - Am Thoracic Soc
... To our knowledge, this is the first long-term randomized trial of the effect of
adding a reduction of AHR to the current goals of asthma treatment. ...
Effect of Long-Term Treatment with Inhaled Budesonide on Adult Height in Children with Asthma -
L Agertoft, S Pedersen - New England Journal of Medicine, 2000 - content.nejm.org
... Update on National Asthma Education and Prevention Program Pediatric Asthma Treatment
Recommendations. ... The effect of asthma and its treatment on growth. Arch. ...
Overcoming barriers to nonadherence in asthma treatment -
BG Bender - The Journal of Allergy and Clinical Immunology, 2002 - Elsevier
... asthma treatment Bruce G. Bender, PhD Denver, Colo ... Consequently, the very nature
of such an asthma treatment regimen produces nonadherence. ...
… , anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma -
W Busse, J Corren, BQ Lanier, M McAlary, A Fowler- … - The Journal of Allergy and Clinical Immunology, 2001 - Elsevier
... is an early and central mediator responsible for the induction and progression of
allergic reactions, it is a promising therapeutic target in asthma treatment. ...
Asthma treatment in pregnancy: A randomized controlled study. -
PJ Wendel, SM Ramin, CRNC Barnett-Hamm, TF Rowe, … - American Journal of Obstetrics & Gynecology, 1996 - pt.wkhealth.com
... July 1996, 175:1 > Asthma treatment in pregnancy:... ... Asthma treatment in pregnancy:
A randomized controlled study. [General Obstetrics And Gynecology]. ...
Regular inhaled beta-agonist treatment in bronchial asthma
MR SEARS, DC LAKE, DM YATES, DR TAYLOR, Q LI, MK … - Lancet(British edition), 1990 - cat.inist.fr
Regular inhaled beta-agonist treatment in bronchial asthma. MR SEARS, DC
LAKE, DM YATES, DR TAYLOR, QINGQING LI, MK LUCAS, CG PRINT ...
Source: Google Scholar |